drugset
drugset / Trial / NCT01139515

Eletriptan Pharmacokinetics In Korean Males

NCT01139515 ↗

Phase 1 Completed 16 enrolled Viatris Inc.
RandomizedCrossoverOpen-labelBasic science

Summary

The hypothesis of this study is that Korean subjects have similar Pharmacokinetics (PK) characteristics to those seen in other populations.

Timeline

Start
2010-07
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Eletriptan Small molecule 20 mg —
Subject Eletriptan Small molecule 40 mg —
Subject Eletriptan Small molecule 80 mg —

Indications

No indication recorded.